Perspectives on mucosal vaccines: Is mucosal tolerance a barrier?

Journal of Immunology

Volumn 179, Issue 9, 2007, Pages 5633-5638

  Mestecky, Jiri ^a,b,d   Russell, Michael W ^c   Elson, Charles O ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIGEN; HAPTEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; MUCOSAL VACCINE; UNCLASSIFIED DRUG; VACCINE; ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ARTHRITIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL PROLIFERATION; DELAYED HYPERSENSITIVITY; DRUG TOLERANCE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; VACCINATION; ANIMAL; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; REVIEW;

ANIMALS; ANTIBODIES; ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION; MUCOUS MEMBRANE; VACCINES;

EID: 38449107450     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.9.5633     Document Type: Short Survey

References (73)

1. Boyaka, P. N., J. R. McGhee, C. Czerkinsky, and J. Mestecky. 2005. Mucosal vaccines: an overview. In Mucosal Immunology, 3rd Ed. J. Mestecky, J. Bienenstock, M. E. Lamm, L. Mayer, J. R. McGhee, and W. Strober, eds. Elsevier/Academic Press, Amsterdam, p. 855-873.
2. Holmgren, J., and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11: S45-S53.
3. Corthesy, B. 2007. Roundtrip ticket for secretory IgA: Role in mucosal homeostasis? J. Immunol. 178: 27-32.
4. Czerkinsky, C., F. Anjuere, J. R. McGhee, A. George-Chandy, J. Holmgren, M. P. Kieny, K. Fujiyashi, J. F. Mestecky, V. Pierrefite-Carle, C. Rask, and J. B. Sun. 1999. Mucosal immunity and tolerance: relevance to vaccine development. Immunol. Rev. 170: 197-222.
5. Mestecky, J., M. W. Russell, and C. O. Elson. 1999. Intestinal IgA: novel views on its function in defense of the largest mucosal surface. Gut 44: 2-5.
6. Mestecky, J., Z. Moldoveanu, S. M. Michalek, C. Morrow, R. W. Compans, D. P. Schafer, and M. W. Russell. 1997. Current options for vaccine delivery systems by mucosal routes. J. Controlled Release 48: 243-257.
7. Mestecky, J., Z. Moldoveanu, and C. O. Elson. 2005. Immune response versus mucosal tolerance to mucosally administered antigens. Vaccine 23: 1800-1803.
8. Mowat, A. M., A. M. C. Faria, and H. L. Weiner. 2005. Oral tolerance: physiologic basis and clinical applications. In Mucosal Immunology, 3rd Ed. J. Mestecky, J. Bienenstock, M. E. Lamm, L. Mayer, J. R. McGhee, and W. Strober, eds. Elsevier/Academic Press, Amsterdam, pp. 487-537.
9. Faria, A. M., and H. L. Weiner. 2005. Oral tolerance. Immunol. Rev. 206: 232-259.
10. Mestecky, J., J. Bienenstock, J. R. McGhee, M. E. Lamm, W. Strober, J. J. Cebra, L. Mayer, and P. L. Ogra. 2005. Historical aspects of mucosal immunology. In Mucosal Immunology, 3rd Ed. J. Mestecky, J. Bienenstock, M. E. Lamm, L. Mayer, J. R. McGhee, and W. Strober, eds. Elsevier/Academic Press, Amsterdam, p. xxxiii.
11. + T cells in the normal gut mucosa. J. Immunol. 160: 754-762.
12. Rask, C., J. Holmgren, M. Fredriksson, M. Lindblad, I. Nordström, J.-B. Sun, and C. Czerkinsky. 1999. Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice. Clin. Exp. Allergy. 30: 1024-1032.
13. Lowney, E. D. 1968. Immunological irresponsiveness to a contact sensitizer in man. J. Invest. Dermatol. 51: 411-417.
14. Lowney, E. D. 1973. Suppression of contact sensitization in man by prior feeding of antigen. J. Invest. Dermatol. 61: 90-93.
15. Husby, S., J. Mestecky, Z. Moldoveanu, S. Holland, and C. O. Elson. 1994. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J. Immunol. 152: 4663-4670.
16. Waldo, F. B., A. W. van den Wall Bake, J. Mestecky, and S. Husby. 1994. Suppression of the immune response by nasal immunization. Clin. Immunol. Immunopathol. 72: 30-34.
17. Matsui, M., D. A. Hafler, and H. L. Weiner. 1996. Pilot study of oral tolerance to keyhole limpet hemocyanin in humans: down-regulation of KLH-reactive precursor-cell frequency. Ann. NY Acad. Sci. 778: 398-404.
18. Kraus, T. A., L. Toy, L. Chan, J. Childs, and L. Mayer. 2004. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 126: 1771-1778.
19. Zivny, J. H., Z. Moldoveanu, H. L. Vu, M. W. Russell, J. Mestecky, and C. O. Elson. 2001. Mechanisms of immune tolerance to food antigens in humans. Clin. Immunol. 101: 158-168.
20. Rothberg, R. M., and R. S. Farr. 1965. Anti-bovine serum albumin and anti-α lactalbumin in the serum of children and adults. Pediatrics 35: 571-588.
21. Russell, M. W., J. Mestecky, B. A. Julian, and J. H. Galla. 1986. IgA-associated renal diseases: antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli. J. Clin. Immunol. 6: 74-86.
22. Kulczycki, A., Jr., G. S. Nash, M. J. Bertovich, H. D. Burack, and R. P. MacDermott. 1987. Bovine milk IgG, but not serum IgG, inhibits pokeweed mitogen-induced antibody secretion by human peripheral blood mononuclear cells. J. Clin. Immunol. 7: 37-45.
23. Gill, S. R., M. Pop, R. T. Deboy, P. B. Eckburg, P. J. Turnbaugh, B. S. Samuel, J. I. Gordon, D. A. Relman, C. M. Fraser-Liggett, and K. E. Nelson. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312: 1355-1359.
24. Ley, R. E., D. A. Peterson, and J. I. Gordon. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124: 837-848.
25. Mestecky, J., I. Moro, M. A. Kerr, and J. M. Woof. 2005. Mucosal immunoglobulins. In Mucosal Immunology, 3rd. Ed. J. Mestecky, J. Bienenstock, M. E. Lamm, L. Mayer, J. R. McGhee, and W. Strober, eds. Elsevier/Academic Press, Amsterdam, p. 153-181.
26. Elson, C. O., Y. Cong, V. J. McCracken, R. A. Dimmitt, R. G. Lorenz, and C. T. Weaver. 2005. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol. Rev. 206: 260-276.
27. Duchmann, R., I. Kaiser, E. Hermann, W. Mayet, K. Ewe, and K. H. Meyer zum Buschenfelde. 1995. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102: 448-455.
28. Macpherson, A. J., D. Gatto, E. Sainsbury, G. R. Harriman, H. Hengartner, and R. M. Zinkernagel. 2000. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288: 2222-2226.
29. Macpherson, A. J., and T. Uhr. 2004. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303: 1662-1665.
30. Konrad, A., Y. Cong, W. Duck, R. Borlaza, and C. O. Elson. 2006. Tight mucosal compartmentation of the murine immune response to antigens of the enteric microbiota. Gastroenterology 130: 2050-2059.
31. Cong, Y., C. T. Weaver, A. Lazenby, and C. O. Elson. 2002. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 169: 6112-6119.
32. Coombes, J. L., N. J. Robinson, K. J. Maloy, H. H. Uhlig, and F. Powrie. 2005. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204: 184-194.
33. Kraehenbuhl, J.-P., and M. Corbett. 2004. Keeping the gut microflora at bay. Science 303: 1624-1625.
34. Ilan, Y. 2004. Oral immune regulation toward disease-associated antigens: results of phase I clinical trials in Crohn's disease and chronic hepatitis. Ann. NY Acad. Sci. 1029: 286-298.
35. Elson, C. O., and W. Ealding. 1984. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133: 2892-2897.
36. Elson, C. O., and M. T. Dertzbaugh. 2005. Mucosal adjuvants. In Mucosal Immunology, 3rd Ed. J. Mestecky, J. Bienenstock, M. E. Lamm, L. Mayer, J. R. McGhee, and W. Strober, eds. Elsevier/Academic Press, Amsterdam, p. 967-986.
37. Hajishengallis, G., S. Arce, C. M. Gockel, T. D. Connell, and M. W. Russell. 2005. Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections. J. Dent. Res. 84: 1104-1116.
38. Russell, M. W., and H.-Y. Wu. 1991. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit. Infect. Immun. 59: 4061-4070.
39. Wu, H.-Y., and M. W. Russell. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61: 314-322.
40. Katz, J., C. C. Harmon, G. P. Buckner, G. J. Richardson, M. W. Russell, and S. M. Michalek. 1993. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin. Infect. Immun. 61: 1964-1971.
41. Sun, J. B., J. Holmgren, and C. Czerkinsky. 1994. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91: 10795-10799.
42. Sun, J. B., C. Rask, T. Olsson, J. Holmgren, and C. Czerkinsky. 1996. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. USA 93: 7196-7201.
43. + regulatory T cells. J. Immunol. 177: 7634-7644.
44. Hajishengallis, G., S. K. Hollingshead, T. Koga, and M. W. Russell. 1995. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J. Immunol. 154: 4322-4332.
45. Martin, M., G. Hajishengallis, D. J. Metzger, S. M. Michalek, T. D. Connell, and M. W. Russell. 2001. Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of T cells. Infect. Immun. 69: 252-261.
46. Gockel, C. M., and M. W. Russell. 2005. Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein. Immunology 116: 477-486.
47. Stanford, M., T. Whittall, L. A. Bergmeier, M. Lindblad, S. Lundin, T. Shinnick, Y. Mizushima, J. Holmgren, and T. Lehner. 2004. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clin. Exp. Immunol. 137: 201-208.
48. Kotloff, K. L., M. B. Sztein, S. S. Wasserman, G. A. Losonsky, S. C. DiLorenzo, and R. I. Walker. 2001. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect. Immun. 69: 3581-3590.
49. Stephenson, I., M. C. Zambon, A. Rudin, A. Colegate, A. Podda, R. Bugarini, G. Del Giudice, A. Minutello, S. Bonnington, J. Holmgren, et al. 2006. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers. J. Virol. 80: 4962-4970.
50. + T cells. Immunology 118: 311-320.
51. Stevens, F. A. 1945. Council on pharmacy and chemistry. Report of the council: status of poison ivy extracts. J. Am. Med. Assoc. 127: 912-921.
52. Klingman, A. M. 1958. Poison ivy (Rhus) dermatitis. Arch. Dermatol. 77: 149-180.
53. Chase, M. W. 1946. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. Med. 61: 257-259.
54. Moldoveanu, Z., F. Oliver, J. Mestecky, and C. O. Elson. 2004. Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration. Ann. NY Acad. Sci. 1029: 299-309.
55. Staines, N. A., C. J. Derry, L. Marinova-Mutafchieva, N. Ali, D. H. Davies, and J. J. Murphy. 2004. Constraints on the efficacy of mucosal tolerance in treatment of human and animal arthritic diseases. Ann. NY Acad. Sci. 1029: 250-259.
56. Weiner, H. L. 2004. Current issues in the treatment of human diseases by mucosal tolerance. Ann. NY Acad. Sci. 1029: 211-224.
57. Fujihashi, K., and J. R. McGhee. 2005. Th1/Th2/Th3 cells for regulation of mucosal immunity, tolerance, and inflammation. In Mucosal Immunology, 3rd Ed. J. Mestecky, J. Bienenstock, M. E. Lamm, L. Mayer, J. R. McGhee, and W. Strober, eds. Elsevier/Academic Press, Amsterdam, p. 539-558.
58. Strober, W., S. Fagarasan, and N. Lycke. 2005. IgA B cell development. In Mucosal Immunology, 3rd Ed. J. Mestecky, J. Bienenstock, M. E. Lamm, L. Mayer, J. R. McGhee, and W. Strober, eds. Elsevier/Academic Press, Amsterdam, pp. 583-616.
59. Brandtzaeg, P., and F.-E. Johansen. 2005. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol. Rev. 206: 32-63.
60. Challacombe, S. J., and T. B. Tomasi, Jr. 1980. Systemic tolerance and secretory immunity after oral immunization. J. Exp. Med. 152: 1459-1472.
61. Woof, J. M., and J. Mestecky. 2005. Mucosal immunoglobulins. Immunol. Rev. 206: 64-82.
62. Russell, M. W., D. A. Sibley, E. B. Nikolova, M. Tomana, and J. Mestecky. 1997. IgA antibody as a non-inflammatory regulator of immunity. Biochem. Soc. Trans. 25: 466-470.
63. Brandtzaeg, P., and K. Tolo. 1977. Mucosal penetrability enhanced by serum-derived antibodies. Nature 266: 262-263.
64. Kaetzel, C. S., and K. Mostov. 2005. Immunoglobulin transport and the polymeric immunoglobulin receptor. In Mucosal Immunology, 3rd. Ed. J. Mestecky, J. Bienenstock, M. E. Lamm, L. Mayer, J. R. McGhee, and W. Strober, eds. Elsevier/Academic Press, Amsterdam, p. 211-250.
65. Husby, S., J. C. Jensenius, and S. E. Svehag. 1985. Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies. Scand. J. Immunol. 22: 83-92.
66. O'Neill, E., J., A. Sundstedt, G. Mazza, K. S. Nicolson, M. Ponsford, L. Saurer, H. Streeter, S. Anderton, and D. C. Wraith. 2004. Natural and induced regulatory T cells. Ann. NY Acad. Sci. 1029: 180-192.
67. Shi, H. N., M. J. Grusby, and C. Nagler-Anderson. 1999. Orally induced peripheral nonresponsiveness is maintained in the absence of functional Th1 or Th2 cells. J. Immunol. 162: 5143-5148.
68. Whitacre, C. C., F. Song, R. M. Wardrop III, K. Campbell, M. McClain, J. Benson, Z. Guan, and I. Gienapp. 2004. Regulation of autoreactive T cell function by oral tolerance to self-antigens. Ann. NY Acad. Sci. 1029: 172-179.
69. Black, C. A., L. C. Rohan, M. Cost, S. C. Watkins, R. Draviam, S. Alber, and R. P. Edwards. 2000. Vaginal mucosa serves as an inductive site for tolerance. J. Immunol. 165: 5077-5083.
70. Fleeton, M., N. Contractor, F. Leon, J. He, D. Wetzel, T. Dermody, A. Iwasaki, and B. Kelsall. 2004. Involvement of dendritic cell subsets in the induction of oral tolerance and immunity. Ann. NY Acad. Sci. 1029: 60-65.
71. Mayer, L., and R. S. Blumberg. 2005. Role of epithelial cells in mucosal antigen presentation. In Mucosal Immunology, 3rd Ed. J. Mestecky, J. Bienenstock, M. E. Lamm, L. Mayer, J. R. McGhee, and W. Strober, eds. Elsevier/Academic Press, Amsterdam, pp. 435-450.
72. Mowat, A. M. 2003. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3: 331-341.
73. Worbs, T., U. Bode, S. Yan, M. W. Hoffmann, G. Hintzen, G. Bernhardt, R. Forster, and O. Pabst. 2006. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 203: 519-527.